financetom
Business
financetom
/
Business
/
Foot Locker has Balanced Upside, Downside Amid Store Closures, Promotional Pressures, UBS Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Foot Locker has Balanced Upside, Downside Amid Store Closures, Promotional Pressures, UBS Says
Sep 6, 2024 1:45 AM

12:35 PM EDT, 09/05/2024 (MT Newswires) -- Foot Locker ( FL ) has a "balanced upside/downside skew" due to potential H2 growth and risks from ongoing store closures and expected promotional pressures, UBS said in a note on Thursday.

The company's store closures suggest continued market share loss, limiting potential price-to-earnings multiple expansion and holding its topline growth at a low level, the firm added.

Foot Locker's ( FL ) non-Nike brands have grown about 13% year-over-year, however, a Nike ( NKE ) slowdown "may offset" its non-Nike ( NKE ) gains, according to the note.

UBS reiterated its neutral rating on Foot Locker's ( FL ) stock and kept the price target at $29.

Shares of the company were down 2.2% in recent trading.

Price: 27.76, Change: -0.60, Percent Change: -2.10

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Madison Square Garden Q4: Topline Growth, Events And Merchandise Lead Charge
Madison Square Garden Q4: Topline Growth, Events And Merchandise Lead Charge
Aug 16, 2024
Madison Square Garden Entertainment Corp ( MSGE ) stock gained after it reported its fiscal fourth-quarter results. Revenue rose 26% year-on-year to $186.1 million, beating the analyst consensus estimate of $169.6 million.  Adjusted EPS loss of $(0.53) missed the analyst consensus loss estimate of $(0.52). Also Read: Madison Square Garden Has Room For ‘Robust Growth’ Thanks To Concert Lineup, Christmas Spectacular: Analyst Revenues from...
Lithium Argentina Closes Pastos Grandes Transaction with Ganfeng Lithium
Lithium Argentina Closes Pastos Grandes Transaction with Ganfeng Lithium
Aug 16, 2024
08:44 AM EDT, 08/16/2024 (MT Newswires) -- Lithium Americas (LAAC.TO) agreed on Friday with a subsidiary of Ganfeng Lithium whereby Ganfeng acquired $70 million new shares of Proyecto Pastos Grandes (PGCo), the company's wholly-owned Argentinian subsidiary holding the Pastos Grandes project in Salta, Argentina. The deal gives Ganfeng a 15% stake in PGCo. The completion of this transaction is an...
Canopy Growth Down Slightly In US Premarket As Reveals CEO Succession Plan; David Klein to Retire at End of Fiscal Year
Canopy Growth Down Slightly In US Premarket As Reveals CEO Succession Plan; David Klein to Retire at End of Fiscal Year
Aug 16, 2024
08:40 AM EDT, 08/16/2024 (MT Newswires) -- Canopy Growth Corporation ( CGC ) , a global cannabis company, was at last look down 0.1% in US premarket on Friday as ait announced that CEO David Klein will be retiring at the conclusion of the company's current fiscal year ending March 31, 2025. Until this date or such time that a...
Update: BioNTech Shares Fall as Phase 3 Trial of Combined Influenza, COVID-19 Vaccine With Pfizer Misses 1 of 2 Immunogenicity Targets
Update: BioNTech Shares Fall as Phase 3 Trial of Combined Influenza, COVID-19 Vaccine With Pfizer Misses 1 of 2 Immunogenicity Targets
Aug 16, 2024
08:39 AM EDT, 08/16/2024 (MT Newswires) -- (Updates with missed target, stock movement in headline and lead paragraph, and additional details.) Shares of BioNTech (BNTX) were down 4% in Friday's premarket session after the biotech firm and Pfizer ( PFE ) reported that their phase 3 study assessing a combined mRNA vaccine candidate targeting influenza and COVID-19 missed one of...
Copyright 2023-2025 - www.financetom.com All Rights Reserved